The utilization of hypnotics in chronic schizophrenics: some critical remarks
- PMID: 41605
The utilization of hypnotics in chronic schizophrenics: some critical remarks
Abstract
Of 23 hospitalized chronic schizophrenic patients, all under neuroleptic medication, hypnotics taken previously for a long time could be totally withdrawn in 16 cases, and in 7 cases, the dosage was diminished by 30%, without any sleep impairment. The gradual reduction of hypnotics was accompanied by a shift of neuroleptic dosage to the evening and bedtime, with reduction of the morning and midday dose, without change of the total daily dose. A significant improvement in the psychic state was observed in 16 patients after withdrawal of the hypnotic; 7 patients showed a slight improvement after reduction of the hypnotic. Monthly or bimonthly reassessment of insomnia in the hospitalized population of chronic schizophrenics is indispensable to avoid the deleterious effects and abuse of hypnotic drugs.
Similar articles
-
Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.Pharmacopsychiatry. 1987 May;20(3):116-9. doi: 10.1055/s-2007-1017087. Pharmacopsychiatry. 1987. PMID: 2885865
-
[Insomnia therapy and withdrawal of hypnotics].Sem Hop. 1982 Nov 18;58(42):2441-9. Sem Hop. 1982. PMID: 6297032 French.
-
Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.J Clin Psychiatry. 1994 Feb;55(2):60-5. J Clin Psychiatry. 1994. PMID: 7915708 Clinical Trial.
-
Zopiclone, the third generation hypnotic: a clinical overview.Int Clin Psychopharmacol. 1990 Apr;5 Suppl 2:147-58. Int Clin Psychopharmacol. 1990. PMID: 2201726 Review.
-
[Novel insomnia drugs, including drugs currently under development].Nihon Rinsho. 2009 Aug;67(8):1590-4. Nihon Rinsho. 2009. PMID: 19768946 Review. Japanese.